Active: new fund Apr 2025 Verified 5 Nov 2026
Vensana Capital
Minneapolis, MN venture capital and growth equity firm investing in development and commercial stage medtech companies, including devices, diagnostics, drug delivery and digital health.
- Type
- VC firm
- Location
- Minneapolis, Minnesota, United States
- Stages
- Growth
- Backs
- Biotech and pharma, Medtech and digital health, Tech-enabled services
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- $425M Vensana Capital III (Form D offering, 2024); $984.1M gross private fund assets (Form ADV; private funds: 3, of which venture capital: 3)
- Latest fund or filing
- 27 Sep 2024
- Website
- www.vensanacap.com
Contacts on file
For Vensana Capital, the paid file holds: 8 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2033799/000203379924000003/
- adviserinfo.sec.gov/firm/summary/300695
- www.vensanacap.com/
- www.vensanacap.com/our-team/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 17 lists
Venture capital firms in Minnesota (20)Growth-stage biotech investors in the US (44)Growth-stage medtech investors in the US (69)Growth-stage medtech investors (107)Growth-stage biotech investors (109)Growth-stage healthtech investors in the US (121)Growth-stage investors in the US (288)Biotech venture capital firms in the US (297)Growth-stage healthtech investors (316)Medtech venture capital firms in the US (350)Medtech investors (457)Biotech investors (484)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Venture capital firms in the US (2,975)